NextFin News - US insurers are ploughing into private credit at the fastest pace in two years, even as the 10-year Treasury yield sits above 5% and government bonds offer the most attractive income since before the global financial crisis. The apparent contradiction is the point: insurers are not chasing yield blindly, they are chasing a structural role that public bonds cannot fill — matching long-dated liabilities with long-duration, illiquid assets while harvesting an illiquidity premium that only private markets pay.
The evidence is in the Marsh 2026 Global Insurance Investments Survey, released in July. More than half (57%) of the 123 insurers surveyed, representing over US$4 trillion in assets, plan to increase their exposure to private credit over the next 12 to 24 months. That makes private credit the single leading area of planned investment growth — ahead of public investment-grade fixed income, cited by 48% — and a sharp reversal from the 2024 survey, when 37% planned to add fixed income and only 32% private credit.
Why does this matter now? Because the backdrop has flipped. The 10-year Treasury yield was 5.24% as of October 16, 2026, up more than a percentage point year-to-date. High-grade public bonds once again pay. Yet insurers are still tilting toward private credit — but selectively, and mostly at the largest end of the market. The combination tells you this is not a simple search-for-yield story. It is a balance-sheet story, and it carries a crowding risk that most of the market is not pricing.
The Numbers: A Selective, Not Broad, Rush
The headline 57% figure hides the important detail: this is a flight to quality within private credit, not a reach for risk. Insurers' allocation priorities concentrate in the investment-grade segment. Forty percent are targeting investment-grade direct lending and private placements; 38% are focused on investment-grade structured credit, asset-based finance, net asset value (NAV) lending and fund finance. Direct, high-yield private credit — the segment that drew the most regulatory scrutiny in 2025–2026 — is not the destination.
Geography splits cleanly. Appetite is strongest in North America: 65% of US insurers and 74% in Canada plan to increase allocations. Europe lags at 51%, and the UK trails at 46%. Scale is the decisive filter: 81% of insurers with more than $25 billion in assets plan to add private credit, versus only 46% of those below that threshold. Life insurers lead at 73%, well ahead of health insurers (56%) and property-and-casualty carriers (40%).
The life-insurer skew is not an accident. Life books carry liabilities that stretch decades into the future. A 10-year Treasury, even at 5.24%, does not match that duration, and rolling short-duration paper exposes the book to reinvestment risk every two or three years. Private credit and private placements can be structured with longer maturities and contractual cash flows that line up against policy obligations. That is asset-liability matching, not yield chasing.
"Private credit is a compelling opportunity for insurers, especially in the asset-backed space. Insurers can diversify away from corporate risk while realizing meaningful yield pickup over similar rated, investment-grade public market bonds," said David Morrow, Mercer's Global Insurance Proposition Leader.
The yield pickup remains real. In the lowest-rated public segments, CCC-or-lower US high-yield bonds offered a spread of 12.5% above Treasuries in October 2026, up from around 8.2% a year earlier, according to data in AllianzGI's October 2026 fixed-income outlook. Private credit sits between investment-grade public credit and that high-yield tail — offering a premium over similarly rated public bonds without the default risk of the weakest issuers. That middle ground is exactly where insurers want to live.
Why Rising Yields Don't Kill the Trade — They Narrow It
The obvious counter-argument is arithmetic. When risk-free government bonds yield above 5%, the case for locking capital into illiquid, opaque, hard-to-value private loans weakens. Every basis point that Treasuries rise shrinks the relative spread that justifies giving up liquidity. On this read, the private-credit boom was a product of the zero-rate era, and higher yields should send insurers back to public bonds.
There is truth in that — and insurers know it. The single most cited concern in the Marsh survey, named by 66% of respondents, is a reduction in the illiquidity premium and tighter spreads. More than half (54%) worry about deteriorating underwriting standards or covenants, and 51% cite rising defaults, wider spreads or payment-in-kind (PIK) structures. These are not the anxieties of investors who believe private credit is a free lunch. They are the anxieties of investors who know the lunch is getting smaller and are deciding whether it is still worth the price.
That is why the structural case matters more than the cyclical one. The cyclical leg of this trade is straightforward: when public yields were near zero, private credit was one of the few places insurers could earn a return. As yields rise, that leg weakens — and it will weaken further if the 10-year keeps climbing toward the 5.60% level where the 30-year bond now trades. This part of the thesis is mean-reverting and rate-sensitive.
But the structural leg is different, and it does not revert on its own. Three forces lock insurers into private markets regardless of the rate cycle. First, regulation: post-crisis capital rules make holding long-duration, lower-rated public credit expensive on a risk-based capital basis, while private placements and certain asset-backed structures can be more capital-efficient for the same economic exposure. Second, supply: the universe of investment-grade public corporate bonds has shrunk relative to the size of institutional balance sheets, so large insurers cannot deploy billions at scale in public IG credit without moving prices against themselves. Third, duration: the liability profile of a life insurer is structurally long, and the public curve simply does not offer enough genuinely long, high-quality paper to match it.
Those three forces are regime-level, not cycle-level. A rate cut next year would make the trade easier; a rate rise would make it harder. Neither changes the underlying geometry.
The Second-Order Risk: Crowding Compresses the Very Premium Insurers Are Buying
Here is the implication the market is not discussing enough. When 81% of the largest insurers all target the same investment-grade, asset-backed, direct-lending slice of private credit, they bid up exactly the segment that is supposed to pay them for illiquidity. The illiquidity premium is not a fixed number nature hands out; it is a price set by the marginal buyer. If the marginal buyers are all the same insurers, with the same mandates, reading the same surveys, the premium compresses — which is precisely what 66% of respondents say they fear.
The compression creates a second-order problem: insurers who still need the premium will be pushed into riskier corners of the market — lower credit quality, weaker covenants, more PIK — even as they tell surveyors they prefer investment grade. That is how private-credit cycles turn. The 2025–2026 wave of private-credit stress, when several large funds restricted redemptions and stressed-loan valuations widened to record gaps, was not caused by a shortage of demand. It was caused by capital chasing a premium that had already been arbitraged away.
The regulatory response is already here, and it is tightening. The NAIC's April 2026 issue brief on private credit and CLOs made clear that state regulators are not treating the asset class as inherently inappropriate — but they are raising the cost of entry. Beginning with 2026 reporting, insurers must disclose far more granular detail on private placements: classification as private investments, fair value, Level 2 and Level 3 exposure, PIK interest, and private letter ratings. The principles-based bond definition, effective January 1, 2025, forces classification by economic substance rather than legal form. The risk-based capital charge on CLO residual tranches has been lifted to 45%. Asset adequacy testing under AG 53 has been strengthened.
The combined effect is a ratchet: private credit is becoming a scale game. Compliance, valuation, modeling and workout capability are fixed costs. Only large insurers can absorb them. That is consistent with the survey's own finding that 81% of insurers above $25 billion plan to increase allocations, while barely half of smaller carriers do. The industry is bifurcating into those who can own private credit directly and those who must access it through managers, partnerships or managed accounts.
"Even the largest insurers recognize they don't have all the capabilities or origination capacity in-house and are looking to outside private credit managers to help fill gaps and boost risk-adjusted yields," said Josh Zwick, a partner in Oliver Wyman's insurance and asset-management practice. "Everyone is looking to build out their capabilities, and that often means finding partners that can help navigate the complexities across different parts of the sprawling private credit market."
The capability gap is the quiet constraint on the whole thesis. Only 30% of surveyed insurers say they have "most" of the private-markets capabilities they need to invest with confidence; another 29% have only "some." More than half (54%) are not using AI in any meaningful way in investment operations, even as AI applications — data integration, scenario generation, document review, manager monitoring, risk analysis — become the differentiator between firms that can underwrite private deals at scale and firms that cannot. Among managers of over $100 billion, 75% report meaningful AI use; among those managing less than $1 billion, only about 10% do.
The Strongest Case Against the Thesis
The bear case is clean and deserves to be stated without softening. Government bonds at 5%+ are offering income levels unseen since before the global financial crisis. They are liquid, transparent, marked daily, and require no manager due diligence, no valuation committee, no capital-model override. If an insurer's only goal is income, the public bond market now wins on a risk-adjusted basis. Wellington Management's 2026 insurer fixed-income ideas note frames private credit as appealing but explicitly flags "private credit fatigue" as a reason some insurers may begin derisking from it. The Marsh survey's own risk rankings — 66% worried about premium compression, 54% about covenant deterioration, 51% about defaults and PIK — read like a checklist of reasons to slow down.
There is also a valuation overhang. Private credit is marked infrequently, and the gap between fund-reported values and stressed-market values widened sharply in 2025–2026. If public credit spreads widen and private marks do not catch down quickly enough, insurers face a double hit: mark-to-model resilience today, mark-to-reality losses tomorrow. The NAIC's push for granular Level 3 disclosure beginning in 2026 reporting is a direct response to that risk — and it will make the overhang more visible, not less.
The answer to the bear case is not that private credit is cheap. It is that insurers are not buying it for today's spread alone. They are buying duration, capital treatment and liability matching — three things a 10-year Treasury does not provide in the quantities a large life book requires. But that answer has a limit. If the 10-year yield climbs another 100 basis points while private-credit spreads compress another 50 to 75 basis points, the structural case starts to look suspiciously like a cyclical one dressed in ALM language.
What to Watch
The thesis is falsifiable, and the signal is concrete. The next Marsh survey should show whether the 57% allocation-intent figure holds. If the share of insurers planning to increase private-credit allocations falls back toward — or below — the 2024 level of 32% while the 10-year Treasury yield remains above 4.5%, the structural-shift thesis is wrong: this was a yield-chasing cycle, and higher rates did the job of cooling it. If the figure holds above 50% despite yields staying elevated, the structural case is confirmed.
Second, watch the spread between private-credit pricing and similarly rated public IG credit. If that spread compresses below historical norms while allocation intent stays high, crowding is winning and the next cycle's losses are being underwritten today. Third, watch the 2026 regulatory disclosures on Level 3 private placements: a step-up in fair-value hairpins would be the first hard evidence that marks are lagging reality.
By time horizon, the picture splits. In the short term (6–12 months), sentiment is bullish but selective — IG, asset-backed, direct lending — and any public-market credit dislocation would pause new commitments as insurers wait for marks to reset. Over the medium term (1–3 years), the flow is supported by liability-driven demand from life insurers and by the capital-efficiency advantage of private placements; this is where the base case lives. Over the long term (5+ years), the trade depends on whether the illiquidity premium survives institutional crowding and whether regulation keeps capital treatment aligned with actual risk. If both hold, private credit becomes a permanent, if smaller-margin, pillar of insurance balance sheets. If either breaks, the rotation back to public bonds will be fast — because unlike private credit, public bonds can be sold.
Insurers are not wrong to want private markets. They may be wrong about how much they can all fit through the same door at once. The premium they are buying is being bid away by the very act of buying it — and when 81% of the largest players agree on the trade, the trade has already become the risk.
Explore more exclusive insights at nextfin.ai.
